Cargando…
Trabectedin Is Active against Two Novel, Patient-Derived Solitary Fibrous Pleural Tumor Cell Lines and Synergizes with Ponatinib
SIMPLE SUMMARY: Solitary fibrous tumor of the pleura (SFT) is an orphan disease resistant to standard systemic therapy. We managed to establish two patient-derived cell models characterized as SFT by the NAB2-STAT6 gene fusion. Cell lines were tested for drug responsiveness in vitro. Trabectedin and...
Autores principales: | Ghanim, Bahil, Baier, Dina, Pirker, Christine, Müllauer, Leonhard, Sinn, Katharina, Lang, Gyoergy, Hoetzenecker, Konrad, Berger, Walter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9688590/ https://www.ncbi.nlm.nih.gov/pubmed/36428694 http://dx.doi.org/10.3390/cancers14225602 |
Ejemplares similares
-
Efficacy of trabectedin in metastatic solitary fibrous tumor
por: Chaigneau, Loïc, et al.
Publicado: (2011) -
Intrathoracic solitary fibrous tumor – an international multicenter study on clinical outcome and novel circulating biomarkers
por: Ghanim, Bahil, et al.
Publicado: (2017) -
Efficacy of trabectedin in malignant solitary fibrous tumors: a retrospective analysis from the French Sarcoma Group
por: Khalifa, J., et al.
Publicado: (2015) -
Solitary fibrous pleural tumor. A rare and challenging case
por: Fatimi, Saulat hasnain, et al.
Publicado: (2019) -
Unique Presentation and Management Approach of Pleural Solitary Fibrous Tumor
por: Aridi, Tarek, et al.
Publicado: (2019)